| Market Cap | ₹441Cr |
| ROE | 3.34% |
| P/E Ratio(TTM) | 60.48 |
| EPS(TTM) | 5.37 |
| P/B Ratio | 1.71 |
| Dividend Yield | 0.29% |
| Industry P/E | 35.31 |
| Book Value | 190.23 |
| Debt to Equity | 0.16 |
| Face Value | 10 |
| Parent Organisation | Medicamen Biotech |
| Managing Director | Shri. Bal Gupta |
| NSE Symbol | MEDICAMEQ |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.69 | ||
| Gland Pharma | NA (0.00%) | 41.16 | ||
| Ajanta Pharma | NA (0.00%) | 32.96 | ||
| Eris Lifesciences | NA (0.00%) | 52.58 |